Spago Nanomedical AB (XSAT:SPAG BTA) Total Assets : kr30.29 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Spago Nanomedical AB Total Assets?

Spago Nanomedical AB's Total Assets for the quarter that ended in Mar. 2025 was kr30.29 Mil.

During the past 12 months, Spago Nanomedical AB's average Total Assets Growth Rate was -59.80% per year. During the past 3 years, the average Total Assets Growth Rate was -62.90% per year. During the past 5 years, the average Total Assets Growth Rate was -48.10% per year. During the past 10 years, the average Total Assets Growth Rate was -12.50% per year.

During the past 13 years, Spago Nanomedical AB's highest 3-Year average Total Assets Growth Rate was 36.70%. The lowest was -62.90%. And the median was 10.00%.

Total Assets is connected with ROA %. Spago Nanomedical AB's annualized ROA % for the quarter that ended in Mar. 2025 was -85.13%. Total Assets is also linked to Revenue through Asset Turnover. Spago Nanomedical AB's Asset Turnover for the quarter that ended in Mar. 2025 was 0.01.

Spago Nanomedical AB Total Assets Historical Data

The historical data trend for Spago Nanomedical AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spago Nanomedical AB Total Assets Chart

Spago Nanomedical AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

162.82

191.62

205.95

52.99

39.58

Spago Nanomedical AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Assets	Get a 7-Day Free Trial															41.47	57.48	47.11	39.58	30.29

Spago Nanomedical AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Spago Nanomedical AB's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	33.235	+	6.348
	=	39.58

Spago Nanomedical AB's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2025 )	+	Total Liabilities (Q: Mar. 2025 )
	=	25.578	+	4.71
	=	30.29

Spago Nanomedical AB (XSAT:SPAG BTA) Total Assets Explanation

Total Assets is connected with ROA %.

Spago Nanomedical AB's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %	=	Net Income (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
	=	-29.74	/	( (39.583	+	30.288)	/ 2 )
	=	-29.74	/	34.9355
	=	-85.13 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Spago Nanomedical AB's Asset Turnover for the quarter that ended in Mar. 2025 is

	Asset Turnover
=	Revenue (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
=	0.338	/	( (39.583	+	30.288)	/ 2 )
=	0.338	/	34.9355
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Spago Nanomedical AB Total Assets Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Spago Nanomedical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (XSAT:SPAG BTA) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

SPAGO:Sweden

Address

Scheelevagen 22, Lund, SWE, SE-223 63

Website

https://www.spagonanomedical.se

Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through the previous detection of tumors and metastases. The Tumorad products focus on the development of a completely new form of radionuclide therapy for tumor-selective radiation therapy of cancer. The company's development projects are based on a platform of polymeric materials with various properties for the precise diagnosis and treatment of life-threatening and debilitating diseases.

Spago Nanomedical AB Headlines

No Headlines